Real-time enrollment status for this advanced renal cell carcinoma (rcc) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:35 PM UTC
| NCT Number | NCT07293351 |
| Recruiting Status | Recruiting |
| Condition | Advanced Renal Cell Carcinoma (RCC) |
| Phase | PHASE1 |
| Target Enrollment | 474 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | August 28, 2026 (Yesterday) |
As of August 29, 2026: Clinical trial NCT07293351 is currently recruiting participants. This phase1 study for advanced renal cell carcinoma (rcc) is actively seeking new participants at 18 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07293351 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07293351 was last updated Yesterday (August 28, 2026). HelloStudys verifies this status automatically.